rindock docket 94e0098 rindock doctitl determin regulatori review period purpos patent extens effexor reg doctitl agenc agenc food drug administr hh agenc action action notic action summari summari food drug administr fda determin regulatori review period effexor reg publish notic determin requir law fda made determin submiss applic commission patent trademark depart commerc extens patent claim human drug product summari address address written comment petit direct docket manag branch hfa305 food drug administr rm 123 12420 parklawn dr rockvil md 20857 address inform contact brian j malkin offic health affair hfy20 food drug administr 5600 fisher lane rockvil md 20857 3014431382 supplem supplementari inform drug price competit patent term restor act 1984 pub l 98417 gener anim drug patent term restor act pub l 100670 gener provid patent may extend period 5 year long patent item human drug product anim drug product medic devic food addit color addit subject regulatori review fda item market act product regulatori review period form basi determin amount extens applic may receiv regulatori review period consist two period time test phase approv phase human drug product test phase begin exempt permit clinic investig drug becom effect run approv phase begin approv phase start initi submiss applic market human drug product continu fda grant permiss market drug product although portion regulatori review period may count toward actual amount extens commission patent trademark may award exampl half test phase must subtract well time may occur patent issu fda determin length regulatori review period human drug product includ test phase approv phase specifi 35 u c 156 g 1 b fda recent approv market human drug product effexor reg venlafaxin hydrochlorid effexor reg indic treatment depress subsequ approv patent trademark offic receiv patent term restor applic effexor reg u patent 4 535 186 american home product corp patent trademark offic request fda assist determin patent elig patent term restor letter date april 22 1994 fda advis patent trademark offic human drug product undergon regulatori review period approv effexor reg repres first permit commerci market use product shortli thereaft patent trademark offic request fda determin product regulatori review period fda determin applic regulatori review period effexor reg 2 959 day time 1 981 day occur test phase regulatori review period 978 day occur approv phase period time deriv follow date 1 date exempt section 505 feder food drug cosmet act becam effect novemb 23 1985 fda verifi applic claim novemb 23 1985 date investig new drug applic ind becam effect 2 date applic initi submit respect human drug product section 505 b feder food drug cosmet act april 26 1991 applic claim june 18 1991 date new drug applic nda effexor reg nda 20151 initi submit howev fda record indic nda 20151 initailli submit april 26 1991 3 date applic approv decemb 28 1993 fda verifi applic claim nda 20151 approv decemb 28 1993 determin regulatori review period establish maximum potenti length patent extens howev u patent trademark offic appli sever statutori limit calcul actual period patent extens applic patent extens applic seek 5 year patent term extens anyon knowledg date publish incorrect may octob 31 1994 submit docket manag branch address written comment ask redetermin furthermor interest person may petit fda februari 27 1995 determin regard whether applic extens act due dilig regulatori review period meet burden petit must contain suffici fact merit fda investig see h rept 857 part 1 98th cong 2d sess pp 4142 1984 petit format specifi 21 cfr 10 30 comment petit submit docket manag branch address three copi except individu may submit singl copi identifi docket number found bracket head document comment petit may seen docket manag branch 9 4 p monday friday date august 16 1994 supplem signer stuart l nightingal signer signjob associ commission health affair signjob frfile fr doc 9421287 file 82994 8 45 frfile bill bill code 416001f bill